Pfizer PFE
NYSE PFE
$29.57 +0.13 (+0.44%)
As of: Oct 16, 2026 · 3:59 PM EDT

Pfizer (PFE) Gains from Investment Securities (2026)

Updated

Pfizer (PFE) reported Gains from Investment Securities of -$155 million for FY2010, compared with -$670 million in FY2009.

Analysis

Pfizer (PFE) Gains from Investment Securities (2026) Analysis & Trends

  • According to Business Quant data, Gains from Investment Securities came in at -$670 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 1.87 Bn
API Access

Pfizer Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=PFE&period=max&api_key=YOUR_API_KEY